Immunogenicity of bivalent omicron (BA.1) booster vaccination after different priming regimens in health-care workers in the Netherlands (SWITCH ON): results from the direct boost group of an open-label, multicentre, randomised controlled trial

Publication | Open Access

DOI Full Paper Access

Citations

References

2023

Year

Ngoc H. Tan, Daryl Geers, Roos S. G. Sablerolles, Wim J. R. Rietdijk, Abraham Goorhuis, Douwe F. Postma, Leo G. Visser, Susanne Bogers, Laura L.A. van Dijk, Lennert Gommers,

The Lancet Infectious Diseases

VaccinationVaccine SafetyDirect Boost GroupPreventive MedicineAllergyBivalent OmicronBooster VaccinationVaccine EfficacyInfection ControlMedicineVaccine ResearchEpidemiology